AZ finds itself on the sick list SHARES in drugs giant AstraZeneca bounced back having slumped to a 19-month low earlier today as US regulators formally blocked the launch of its new blood-thinning treatment Exanta. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 